Molecular and Cellular Basis of Cardiovascular Gender Differences
By M. Mendelsohn, R. Karas. Science, 2005
1,118 citations recorded by the source corpus.
Subfields: Endocrinology, Diabetes and Metabolism, Genetics, Public Health, Environmental and Occupational Health
View Paper: https://www.semanticscholar.org/paper/92eb381fdc31bf53baeca6def2dd70bfc2afda92
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrinology, Diabetes and Metabolism
In Genetics
In Public Health, Environmental and Occupational Health
Citations in the corpus
- Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. (2007, positive): “that estrogen may delay the onset of the earliest stages of atherosclerosis, which are more likely to be present in younger women, but it may be ineffective or even trigger events in the presence of existing advanced lesions such as those found in older women.(7) The potential existence of a window ”
- The G protein-coupled estrogen receptor GPER in health and disease (2011, background): “These protective effects are largely attributed to signaling via nuclear ERα”